UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 10, 2025 scPharmaceuticals Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) 25 Mall Road, Suite 203 Burlington, Massachusetts 01803 (Address of principal executive offices) (Zip Code) (Commission File Number) Delaware 001-38293 4 ...